|
2025
|
Invention
|
Vidofludimus and related structures acting as nurr1 agonists.
The present invention relates to m... |
|
|
Invention
|
Triazolo compounds for treatment of bile acid diarrhea and autoimmune enteropathy. The present in... |
|
|
Invention
|
Nurr1 agonists with replacement of the carboxylic acid or carboxamide moiety for use in the treat... |
|
|
Invention
|
Triazolo compounds for use in the treatment of graft-versus-host disease. The present invention r... |
|
|
Invention
|
Reducing body weight and/or induction of satiety by triazolo compounds. The present invention rel... |
|
|
Invention
|
Synthesis of vidofludimus and its calcium salt. The invention relates to the process of preparati... |
|
|
P/S
|
Pharmaceutical preparations. Pharmaceutical research and development. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of multiple sclerosis and Parkinson's disease Pharm... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune and inflammatory diseases Pharmaceuti... |
|
2024
|
Invention
|
Treatment of multiple schlerosis comprising dhodh inhibitors.
Methods of treating or amelioratin... |
|
|
Invention
|
Oral pharmaceutical dosage form providing immediate release of vidofludimus |
|
|
Invention
|
Oral pharmaceutical dosage form providing immediate release of vidofludimus. in vitro in vitro co... |
|
|
Invention
|
Oral pharmaceutical dosage form providing immediate release of vidofludimus. in vitroin vitro con... |
|
|
Invention
|
Heteroaromatic dhodh inhibitors. The present relates to novel dihydroorotate dehydrogenase (DHODH... |
|
|
Invention
|
Heteroaromatic dhodh inhibitors |
|
|
Invention
|
Deuterated analogs of sirtuin 6 modulator imu-856. The present disclosure relates to novel deuter... |
|
|
Invention
|
Calcium salt polymorphs as anti-inflammatory, immunodulatory and anti-proliferative agents.
Subj... |
|
|
Invention
|
Treatment of inflammatory conditions comprising imu-856 |
|
|
Invention
|
Treatment of inflammatory conditions comprising imu-856. The present invention relates to the sir... |
|
|
Invention
|
Vidofludimus and related structures acting as nurr1 agonists. The present invention relates to me... |
|
|
Invention
|
Vidofludimus and related structures acting as nurr1 agonists |
|
2023
|
Invention
|
Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/o... |
|
|
Invention
|
Treatment of multiple sclerosis comprising dhodh inhibitors. Methods of treating or ameliorating ... |
|
|
Invention
|
Treatment of ulcerative colitis comprising vidofludimus or a pharmaceutically acceptable salt the... |
|
|
Invention
|
Rorg/rorgt modulators for the treatment of virus infections like covid-19. The present invention ... |
|
|
Invention
|
New deuterated rorgamma/rorgammat inverse agonists.
The invention relates to novel deuterated co... |
|
|
Invention
|
Deuterated rorgamma/rorgammat inverse agonists. The application relates to isoxazolyl-pyrazole de... |
|
2022
|
Invention
|
Dhodh inhibitors containing a carboxylic acid bioisostere.
The invention relates to novel, optio... |
|
|
Invention
|
Dhodh inhibitors containing a carboxylic acid bioisostere. The invention relates to novel, option... |
|
|
Invention
|
Medical use of n4-hydroxy citicoline compounds.
The present disclosure relates to the medical us... |
|
|
Invention
|
Medical use of n4-hydroxy citicoline compounds. The present disclosure relates to the medical use... |
|
|
Invention
|
Methods for treating cancer.
The present invention provides methods comprising one or compounds ... |
|
|
Invention
|
Methods for treating cancer. The present invention provides methods comprising one or compounds a... |
|
|
Invention
|
Vidofludimus for use in the treatment or prevention of viral diseases. The present invention rela... |
|
|
Invention
|
Deuterated dhodh inhibitors.
The invention relates to novel deuterated compounds of Formula (I)
... |
|
|
Invention
|
Deuterated dhodh inhibitors. The invention relates to novel deuterated compounds of Formula (I) a... |
|
2021
|
P/S
|
Pharmaceutical preparations for the treatment of chronic inflammatory diseases; Pharmaceutical pr... |
|
|
P/S
|
Pharmaceutical drugs; pharmaceutical preparations;
Immunomodulators; pharmaceutical preparations... |
|
2020
|
P/S
|
Pharmaceutical drugs; Pharmaceutical preparations; Immunomodulators; Pharmaceutical preparations ... |
|
2019
|
Invention
|
Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents. Sub... |
|
|
Invention
|
Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agents. Dis... |
|
|
Invention
|
Novel calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferatory agent... |
|
2018
|
Invention
|
Dosage regimen of vidofludimus for use in the prevention or treatment of chronic inflammatory and... |
|
|
Invention
|
Il-17 and ifn-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation.... |
|
|
Invention
|
1-(4-(isoxazol-5-yl)-1h-pyrazol-1-yl)-2-methylpropan-2-ol derivatives and related compounds as il... |
